Peter D.o. Donhauser - 03 Nov 2026 Form 4 Insider Report for ANAVEX LIFE SCIENCES CORP. (AVXL)

Reporting relationship: Director
Issuer ticker: AVXL
Reported as of: 03 Nov 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Nov 2026, 20:14:15 UTC
Prior SEC filing: 02 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/Peter Donhauser

Filing notes and source

Key filing fact

Peter D.o. Donhauser filed Form 4 for ANAVEX LIFE SCIENCES CORP. (AVXL) on 06 Nov 2026.

Key facts

This page summarizes Peter D.o. Donhauser's Form 4 filing for ANAVEX LIFE SCIENCES CORP. (AVXL).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 Nov 2026, 20:14.

Change

Previous filing in this sequence was filed on 02 Apr 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001698234 Primary reporting owner

Donhauser Peter D.O.

Relationship: Director
Address: 630 5TH AVENUE 20TH FLOOR, NEW YORK
Signature: /s/Peter Donhauser
Signature date: 06 Nov 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AVXL transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +50,000
Change %
Price: $0.000000^*
Shares after: 50,000
Date: 03 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price: $1.20
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests in three substantially equal annual installments beginning on March 31, 2027

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .